| Mrs Pamela R Bankston, MS, CCC-SLP | |
|
208 Sweetwater Rim, Pineville, LA 71360-5691 | |
| (318) 419-8176 | |
| Not Available |
| Full Name | Mrs Pamela R Bankston |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 208 Sweetwater Rim, Pineville, Louisiana |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053597351 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 5289 (Louisiana) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Pamela R Bankston, MS, CCC-SLP Po Box 486, Livingston, LA 70754-0486 Ph: (225) 686-8810 | Mrs Pamela R Bankston, MS, CCC-SLP 208 Sweetwater Rim, Pineville, LA 71360-5691 Ph: (318) 419-8176 |
News Archive
"Jon Kingsdale, head of the quasi-state agency that oversees Massachusetts' landmark health law, is stepping down June 4, Governor Deval Patrick said yesterday."
Chief Medical Information Officers (CMIOs) are playing increasingly key roles in their healthcare organizations with EMR projects and the move toward ACOs and most expect to receive a raise and a bonus this year, according to the CMIO Compensation Survey 2012 published in the February issue of CMIO.
The first American patient with COVID-19 and acute respiratory distress syndrome (ARDS) has been put on the drug gimsilumab at Temple University Hospital, as part of the BREATHE clinical trial. The trial, sponsored by Roivant Sciences, will evaluate the effectiveness of intravenous gimsilumab in preventing death in patients with COVID-19 and ARDS.
NaturalNano, Inc. announced today that Dr. Michael King, a researcher at Cornell University, has published a new study demonstrating how NaturalNano nanotubes can improve targeting of circulating tumor cells (CTC's). These nanotubes, when added to the surface where cancer cells are attracted, enhance the natural rolling mechanism that Dr. King believes will allow them to be exposed to specific drugs or other therapeutic agents, or isolated for diagnostic and research purposes.
› Verified 1 days ago
Amanda Lacroix, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 8717 Ridgemont Dr, Pineville, LA 71360 Phone: 318-419-1520 | |
Mrs. Glynda T. Richard, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 208 Sweetwater Rim, Pineville, LA 71360 Phone: 888-735-9403 | |
Erin Bordelon Wilson, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 818 Main St Ste C, Pineville, LA 71360 Phone: 318-446-0601 | |
Carol Martin, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 100 Pinecrest Dr, Pineville, LA 71360 Phone: 318-641-2000 Fax: 318-641-2309 | |
Andrea Marie Vanburen, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 818 Main St Ste C, Pineville, LA 71360 Phone: 318-691-0898 | |
Laura L Odom, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2495 Shreveport Hwy # 71, Pineville, LA 71360 Phone: 318-473-0010 Fax: 318-483-5117 |